(800) 369-0899
(215) 569-4000

Contact Us Today



← Older posts

New Jersey Mesothelioma Attorneys Encouraged By Secured Funding For Mesothelioma Research

The House Appropriations Committee has made mesothelioma research eligible for funding through the FY2014 Defense Appropriations Bill.  The bill, passed in June, includes a provision for a Peer Reviewed Cancer Research Program, and mesothelioma is listed as one of the included research topics.  This is the third year that mesothelioma has been included in the » Read More

Philadelphia Asbestos Lawyers: Asbestos Concerns As Collapsed Site Cleared

New questions are coming to light regarding the building collapse in Center City on June 5, 2013.  An accident during demolition of the building at 22nd and Market Streets caused the building to topple onto an adjacent Salvation Army Thrift Store, killing 6 people.  As the debris is being cleared from the site, the presence » Read More

Philadelphia Mesothelioma Attorneys Report on Orphan Drug Designation for Verastem Inc.

As reported in the Wall Street Journal online Verastem Inc. has been granted orphan drug status from the European Medicines Agency (EMA) for the use of VS-6063 as an investigational treatment for mesothelioma.  Mesothelioma, an aggressive and rare cancer for which there is no cure, is caused by an asbestos exposure.  Mesothelioma typically affects the lining » Read More

Philadelphia Asbestos Lawyers: Illegally Removing Asbestos – Nestle Plant Owner Pleads Guilty

Our Philadelphia asbestos attorneys recently learned that the owner of the former Nestle Plant in Fulton, New York, has pled guilty in a federal court for violating the Clean Air Act when he illegally removed friable asbestos from the property.  The building, which has been closed since 2003, contained approximately 2,000 feet of pipes containing asbestos » Read More

← Older posts